Bupropion Hydrochloride Tablet, Film Coated, Extended Release
Product Images NDC 70518-3790

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Bupropion Hydrochloride (NDC 70518-3790). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Remedy_label (Remedy Label)

Remedy_label (Remedy Label)
This is a description of a medication. The medication is Bupropion HCI Extended-Release (XL) in a 300 mg tablet form. The pack contains 30 tablets. The medication is prescribed and is only available with a prescription (Rx only). The National Drug Code (NDC) for this medication is 70518-3790-00. The manufacturer of the medication is ScieGen Pharmaceuticals, Inc. located in Hauppauge, NY. The medication should be stored at a temperature between 20-25°C (88-77°F) with excursions permitted between 15-30°C (59-86°F) as per USP guidelines. The repackaging of the medication has been done by RemedyRepack Inc. located in Indiana, PA with contact number 724.465.8762. Please refer to the package insert for directions on how to use the medication. It is important to keep this medication and all medications out of the reach of children.*
FDA Label Image

Bupropion Hydrochloride Chemical Structure (Bupropion Hydrochloride Sr 1)

Bupropion Hydrochloride Chemical Structure (Bupropion Hydrochloride Sr 1)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.